These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 31093272)
41. [Epigenetic mechanisms of Alzheimer's disease and related drug research]. Gong HC; Wang YL; Wang HW Yao Xue Xue Bao; 2013 Jul; 48(7):1005-13. PubMed ID: 24133967 [TBL] [Abstract][Full Text] [Related]
42. Current advances in epigenetic modification and alteration during mammalian ovarian folliculogenesis. Pan Z; Zhang J; Li Q; Li Y; Shi F; Xie Z; Liu H J Genet Genomics; 2012 Mar; 39(3):111-23. PubMed ID: 22464470 [TBL] [Abstract][Full Text] [Related]
43. Impaired mitochondrial energy metabolism in Alzheimer's disease: Impact on pathogenesis via disturbed epigenetic regulation of chromatin landscape. Salminen A; Haapasalo A; Kauppinen A; Kaarniranta K; Soininen H; Hiltunen M Prog Neurobiol; 2015 Aug; 131():1-20. PubMed ID: 26001589 [TBL] [Abstract][Full Text] [Related]
44. DNA methylation signature of human hippocampus in Alzheimer's disease is linked to neurogenesis. Altuna M; Urdánoz-Casado A; Sánchez-Ruiz de Gordoa J; Zelaya MV; Labarga A; Lepesant JMJ; Roldán M; Blanco-Luquin I; Perdones Á; Larumbe R; Jericó I; Echavarri C; Méndez-López I; Di Stefano L; Mendioroz M Clin Epigenetics; 2019 Jun; 11(1):91. PubMed ID: 31217032 [TBL] [Abstract][Full Text] [Related]
46. Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain. Coppieters N; Dieriks BV; Lill C; Faull RL; Curtis MA; Dragunow M Neurobiol Aging; 2014 Jun; 35(6):1334-44. PubMed ID: 24387984 [TBL] [Abstract][Full Text] [Related]
47. Epigenetic Regulation of Neuroinflammation in Alzheimer's Disease. Ma Y; Wang W; Liu S; Qiao X; Xing Y; Zhou Q; Zhang Z Cells; 2023 Dec; 13(1):. PubMed ID: 38201283 [TBL] [Abstract][Full Text] [Related]
48. [Epigenetic alterations in acute lymphoblastic leukemia]. Navarrete-Meneses MDP; Pérez-Vera P Bol Med Hosp Infant Mex; 2017; 74(4):243-264. PubMed ID: 29382514 [TBL] [Abstract][Full Text] [Related]
49. Heavy metals toxicity on epigenetic modifications in the pathogenesis of Alzheimer's disease (AD). Venkatesan D; Muthukumar S; Iyer M; Babu HWS; Gopalakrishnan AV; Yadav MK; Vellingiri B J Biochem Mol Toxicol; 2024 Jun; 38(6):e23741. PubMed ID: 38816991 [TBL] [Abstract][Full Text] [Related]
50. Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer's disease. Li SQ; Yu Y; Han JZ; Wang D; Liu J; Qian F; Fan GH; Bucala R; Ye RD J Neuroinflammation; 2015 Sep; 12():177. PubMed ID: 26382037 [TBL] [Abstract][Full Text] [Related]
51. Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells. Jiang Y; Xu B; Chen J; Sui Y; Ren L; Li J; Zhang H; Guo L; Sun X Med Sci Monit; 2018 Aug; 24():5635-5644. PubMed ID: 30102687 [TBL] [Abstract][Full Text] [Related]
52. Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease. Folwell J; Cowan CM; Ubhi KK; Shiabh H; Newman TA; Shepherd D; Mudher A Exp Neurol; 2010 Jun; 223(2):401-9. PubMed ID: 19782075 [TBL] [Abstract][Full Text] [Related]
53. Dysregulation of Epigenetic Mechanisms of Gene Expression in the Pathologies of Hyperhomocysteinemia. Perła-Kaján J; Jakubowski H Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31252610 [TBL] [Abstract][Full Text] [Related]
54. Alzheimer's disease: the potential of epigenetic treatments and current clinical candidates. Coneys R; Wood IC Neurodegener Dis Manag; 2020 Jun; 10(3):543-558. PubMed ID: 32552286 [TBL] [Abstract][Full Text] [Related]
55. Epigenetics in endometrial carcinogenesis - part 2: histone modifications, chromatin remodeling and noncoding RNAs. Bartosch C; Lopes JM; Jerónimo C Epigenomics; 2017 Jun; 9(6):873-892. PubMed ID: 28523964 [TBL] [Abstract][Full Text] [Related]
56. Promoter hypermethylation of the phosphatase DUSP22 mediates PKA-dependent TAU phosphorylation and CREB activation in Alzheimer's disease. Sanchez-Mut JV; Aso E; Heyn H; Matsuda T; Bock C; Ferrer I; Esteller M Hippocampus; 2014 Apr; 24(4):363-8. PubMed ID: 24436131 [TBL] [Abstract][Full Text] [Related]
57. [Intensive protein synthesis in neurons and phosphorylation of beta-amyloid precursor protein and tau-protein are triggering factors of neuronal amyloidosis and Alzheimer's disease]. Mal'tsev AV; Davidchenko NV; Uteshev VK; Sokolik VV; Shtang OM; Iakushun MA; Sokolova NM; Suprin AK; Galzitskaia OV Biomed Khim; 2013; 59(2):144-70. PubMed ID: 23789343 [TBL] [Abstract][Full Text] [Related]
58. Endoplasmic reticulum stress mediates JNK-dependent IRS-1 serine phosphorylation and results in Tau hyperphosphorylation in amyloid β oligomer-treated PC12 cells and primary neurons. Zhang X; Tang S; Zhang Q; Shao W; Han X; Wang Y; Du Y Gene; 2016 Aug; 587(2):183-93. PubMed ID: 27185631 [TBL] [Abstract][Full Text] [Related]
59. Expression of P301L-hTau in mouse MEC induces hippocampus-dependent memory deficit. Liu X; Zeng K; Li M; Wang Q; Liu R; Zhang B; Wang JZ; Shu X; Wang X Sci Rep; 2017 Jun; 7(1):3914. PubMed ID: 28634382 [TBL] [Abstract][Full Text] [Related]